Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 7/20 | 0.33 |
| ▸ | SYK | P43405 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21755836 | 0.86 | SYK (0.38) | ERN1SYKNPC1ALDH1A1MAPT | |
| SCHEMBL30078023 | 0.85 | SYK (0.40) | ERN1SYKNPC1ALDH1A1MAPT | |
| SCHEMBL15065522 | 0.85 | SYK (0.40) | ERN1SYKNPC1ALDH1A1MAPT | |
| SCHEMBL21755806 | 0.84 | SYK (0.34) | ERN1SYKNPC1ALDH1A1MAPT | |
| SCHEMBL30078095 | 0.83 | KDM4E (0.42) | ERN1SYKNPC1ALDH1A1MAPT | |
| SCHEMBL15066126 | 0.83 | KDM4E (0.42) | ERN1SYKNPC1ALDH1A1MAPT | |
| SCHEMBL15065402 | 0.83 | PARP1 (0.39) | ERN1SYKNPC1ALDH1A1MAPT | |
| SCHEMBL21755841 | 0.82 | ERN1 (0.32) | ERN1NPC1ALDH1A1MAPTHTT | |
| SCHEMBL16549759 | 0.82 | ERN1 (0.33) | ERN1SYKNPC1ALDH1A1MAPT | |
| SCHEMBL21755834 | 0.81 | ERN1 (0.32) | ERN1NPC1ALDH1A1MAPTHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2797597-B1 | SUBSTITUTED HETEROARYL ALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | GLOBAL BLOOD THERAPEUTICS INC (US) | 2020-02-26 | — | — | EP | disclosed |